scholarworks.indianapolis.iu.edu
Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study
Cure8 flagged this item because the article title and available source metadata connect it to Crohn's disease, Inflammatory bowel disease, Ustekinumab, and IL-12/23 inhibitor. We do not yet have enough reliable article text to summarize the details.
This may be most useful for Pediatric Patients and Researchers following Crohn's disease, Inflammatory bowel disease, Ustekinumab, IL-12/23 inhibitor, and Medications.
What To Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, Ustekinumab, and IL-12/23 inhibitor. Use the original source link for the full details.
Study details such as design, patient population, comparison group, and measured outcomes matter. The original source has the full context.
